Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Harpoon Therapeutics, Inc. (HARP)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Jun-05-22 | Mar-31-22 |
| | 10-Q | 10-Q | 10-K | 10-Q | 8-K | 10-Q | 8-K | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 79.9% | 0.0% | 240.9% | 0.0% | | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | -140.9% | 100.0% | | 100.0% |
| Selling, general and administrative | | 210.2% | | 257.1% | | | | 466.4% |
| Research and development | 26.2% | | | | | 89.7% | | |
| General and administrative | 57.2% | | 101.5% | | 62.8% | 134.4% | | |
| Depreciation | 4.9% | 7.2% | 7.5% | 7.0% | | 9.8% | | 11.0% |
| EBIT | -79.9% | -169.9% | -214.1% | -221.3% | -221.3% | -329.9% | | -366.4% |
| Pre-tax income | -86.7% | -169.8% | -212.2% | -220.4% | -220.4% | -329.8% | | -366.5% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | 0.0% |
| Net income | -86.7% | -169.8% | -212.2% | -220.4% | -220.4% | -329.8% | | -366.5% |
|